Recommended Treatment for Melasma
Start with topical triple combination cream (hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%) combined with strict broad-spectrum photoprotection, as this remains the gold standard FDA-approved treatment with demonstrated efficacy across all ethnicities. 1, 2, 3, 4
First-Line Topical Therapy
- Triple combination cream (TCC) is the most effective topical treatment, showing superior results to monotherapy with acceptable side effects (25.7% adverse event rate, primarily mild skin irritation) 1, 5, 3
- Hydroquinone 4% alone is an effective alternative if TCC is unavailable or not tolerated 1, 2, 3
- Alternative topical agents include azelaic acid, kojic acid, and topical tranexamic acid for patients who cannot use hydroquinone 1, 4
- All topical treatments must be paired with rigorous photoprotection using broad-spectrum sunscreens containing zinc oxide, iron oxide, and titanium dioxide 1, 2, 6, 4
Adjunctive Procedural Therapies
When topical therapy alone provides insufficient improvement after 8-12 weeks:
- Platelet-rich plasma (PRP) intradermal injections show significant efficacy with high patient satisfaction (>90% pleased with results), demonstrating superior results compared to tranexamic acid injections in most studies 1
- Microneedling with PRP is more effective than intradermal PRP injections alone for administration 1
- Chemical peels can enhance topical efficacy but carry risk of post-inflammatory hyperpigmentation, particularly in darker skin types 7, 8, 4
- Q-switched Nd:YAG 1064-nm laser and ablative fractional lasers rank highest among photoelectric devices for efficacy but should be reserved for refractory cases due to higher adverse event rates (20-21.5%) 5, 9
Systemic Therapy
- Oral tranexamic acid (250 mg twice daily) is highly effective for moderate to severe recurrent melasma, with lower side effect rates (17.6%) compared to procedural interventions 1, 5, 3
- Combination of oral tranexamic acid with PRP shows superior efficacy (90.48% total efficacy) compared to tranexamic acid alone (73.68%), with lower recurrence rates at 6 months 1
Treatment Algorithm
Initial assessment: Perform Wood's lamp examination and dermatoscopic evaluation to determine melasma subtype (epidermal vs. dermal vs. mixed) 7
Eliminate triggers: Address UV exposure, hormonal factors, and discontinue potentially causative medications 1, 6
Start topical therapy: Triple combination cream nightly with strict daily photoprotection 1, 4
Reassess at 8-12 weeks: If inadequate response, add procedural therapy (PRP with microneedling preferred) or oral tranexamic acid 1, 6
Maintenance phase: Once clinical remission achieved, continue topical depigmenting agents and photoprotection indefinitely, as melasma is a chronic relapsing condition requiring regular follow-up 1, 6
Critical Clinical Considerations
- Combination therapies are superior to monotherapy in 87% of studies, yielding the best outcomes 1, 5
- PRP works best with effective home care and adequate sun protection; treat melasma as a chronic condition requiring regular follow-ups 1
- Avoid laser therapy as first-line in darker skin types (Fitzpatrick III-VI) due to high risk of post-inflammatory hyperpigmentation 2, 7
- Side effects are generally mild across all treatments, consisting primarily of skin irritation, dryness, burning, and erythema 5, 3
- Recurrence rates remain high across all treatment modalities, necessitating long-term maintenance strategies 7, 8, 6